Immunohistochemical expression of estrogen receptors in chondrosarcomas and enchondromas

International Journal of Surgical Pathology

Volumn 16, Issue 1, 2008, Pages 31-37

  Grifone, Thomas J ^a   Haupt, Helen M ^a,b   Podolski, Victoria ^a   Brooks, John J ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

^b Department of Pathology ^*  (United States)

Author keywords

Chondrosarcoma; Enchondroma; Estrogen receptor ; Estrogen receptor ; Immunohistochemical

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ADULT; ARTICLE; CHONDROSARCOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENCHONDROMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

CHONDROMA; CHONDROSARCOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTORS, ESTROGEN;

EID: 37549046081     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896907306774     Document Type: Article

References (22)

1. Gruber CJ, Tschugguel W., Schneeberger C., et al. Production and actions of estrogens. N Engl J Med. 2002 ; 346: 340-352.
2. Krishnan V., Heath H., Bryant HU Mechanism of action of estrogens and selective estrogen receptor modulators. Vitam Horm. 2000 ; 60: 123-147.
3. McDonnell DP, Wijayaratne A., Chang C., Norris JD Elucidation of molecular mechanism of action of selective estrogen receptor modulators. Am J Cardiol. 2002 ; 90: F35 - F43.
4. Bovee JV, Clenton-Jansen AM, Taminiau AHM, Hogendoorn P. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol. 2005 ; 6: 599-607.
5. Richette P., Dumontier MF, Francois M., et al. Dual effects of 17β-oestradiol on interleukin 1β-induced proteoglycan degradation in chondrocytes. Ann Rheum Dis. 2004 ; 63: 191-199.
6. Rodd C., Jourdain N., Alini M. Action of estradiol on epiphyseal growth plate chondrocytes. Calcif Tissue Int. 2004 ; 75: 214-224.
7. Cleton-Jansen AM, van Beerendonk HM, Baelde HJ, Bovee JV, Karperien M., Hogendoorn PC Estrogen signaling is active in chondrosarcoma: implications for antiestrogens as treatment of chondrosarcoma. Mod Pathol. 2005 ; 18: 12A.
8. Vigorita VJ Orthopaedic Pathology. Philadelphia, PA: Lippincott Williams and Wilkins ; 1999.
9. Brandon DD, Erickson TE, Keenan EJ, et al. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab. 1995 ; 80: 1876-1881.
10. Aubry MC, Myers JL, Colby TV, Leslie KO, Tazelaar HD Endometrial stromal sarcoma metastatic to the lung: a detailed analysis of 16 patients. Am J Surg Pathol. 2002 ; 26: 440-449.
11. Ohori NP, Yousem SA, Sonmez-Alpan E., Colby TV Estrogen and progesterone receptors in lymphangioleiomyomatosis, epithelioid hemangioendothelioma, and sclerosing hemangioma of the lung. Am J Clin Pathol. 1991 ; 96: 529-535.
12. Olivera P., Perez E., Ortega A., et al. Estrogen receptor expression in giant cell tumors of the bone. Hum Pathol. 2002 ; 33: 165-169.
13. Montag AG, Tretiakova M., Richardsson M. Steroid hormone receptor expression in nasopharyngeal angiofibromas. Am J Clin Pathol. 2006 ; 125: 832-837.
14. Grohe C., Kahlert S., Lobbert K., et al. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett. 1997 ; 416: 107-112.
15. Wilcken N., Tattersall MHN. Endocrine therapy for desmoid tumors. Cancer. 1991 ; 68: 1384-1388.
16. Sportiello DJ, Hoogerland DL A recurrent pelvic desmoid tumor successfully treated with tamoxifen. Cancer. 1991 ; 67: 1443-1446.
17. Clark CP, Vanderpool D., Preskitt JT The response of retroperitoneal fibrosis to tamoxifen. Surgery. 1991 ; 109: 502-506.
18. Fletcher CDM, Unni KK, Mertens F, eds. Pathology and Genetics of Tumors of Soft Tissue and Bone.: Lyon, France: IARC Press ; 2002.
19. Ishibashi H., Suzuki T., Suzuki S., et al. Progesterone receptor in non-small cell lung cancer-a potent prognostic factor and possible target for endocrine therapy. Cancer Res. 2005 ; 65: 6450-6458.
20. Jensen EV, Jordan VC The estrogen receptor: a model for molecular medicine. Clin Cancer Res. 2003 ; 9: 1980-1989.
21. McCloskey E. Effects of third generation aromatase inhibitors on bone. Eur J Cancer. 2006 ; 42 ; 1044-1051.
22. Riggs BL, Hartmann LC Selected estrogen-receptor modulators-mechanisms of action and application to clinical practice. N Engl J Med. 2006 ; 618-629.